Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Address
High-tech Industrial Development Zone
Zhenjiang, 212000
China
Phone
86 51 1888 98101
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1327
First IPO Date
May 18, 2020
| Name | Title | Pay | Year Born |
| Suofu Zhao | Financial Director | 0 | 1967 |
| Zhongyi Geng | GM & Chairman of the Board | 0 | 1963 |
| Zhi Lei Zhu | Accounting Supervisor | 0 | N/A |
| Xiugen Wu | Institute Director | 0 | 1965 |
| Ying Wu | Deputy General Manager | 0 | 1952 |
| Zhaoguang Li | Director of the Synthesis Office of the Research Institute | 0 | 1981 |
| Xufeng Qin | Deputy Director of the Research Institute | 0 | 1974 |
| Jianzhong Zhai | Board Secretary | 0 | 1972 |
| Haidao Li | Deputy Director of the Research Institute | 0 | 1983 |
| Xinjun Yu | Vice Chairman of the Board & Deputy GM | 0 | 1961 |
Jiangsu Jibeier Pharmaceutical Co., Ltd. is a pharmaceutical enterprise based in Zhenjiang, China, established in 2001. The company's core operations involve the research, development, manufacturing, and sales of a diverse range of pharmaceutical products, including chemical preparations, traditional Chinese medicine formulations, and active pharmaceutical ingredients (APIs). Its product portfolio addresses various health concerns, offering solutions for boosting white blood cell counts, enhancing the immune system, treating joint-related ailments, managing high blood pressure, combating ocular infections, alleviating bronchitis symptoms, and protecting liver function, among others. Additionally, Jiangsu Jibeier is actively engaged in developing new therapeutic drugs, with its pipeline focusing on treatments for conditions such as depression, oncology (tumors), and gastrointestinal disorders.